Risk Factors for Artificial Urinary Sphincter Explantation and Erosion in Male Nonneurological Patients
| Autor: | Alice Pitout, Pierre Lecoanet, Charles Mazeaud, Victor Gaillard, Baptiste Poussot, Thibault Tricard, Christian Saussine, Thibaut Brierre, Xavier Game, Florian Beraud, Xavier Biardeau, Franck Bruyere, Damien Robin, Mehdi El-Akri, Daniel Chevallier, Tiffany Cousin, Grégoire Capon, Jean-Nicolas Cornu, Hugo Dupuis, Hervé Monsaint, Nicolas Hermieu, Jean-François Hermieu, Priscilla Léon, Benoit Peyronnet, Imad Bentellis |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | International Neurourology Journal, Vol 28, Iss 2, Pp 147-155 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2093-4777 2093-6931 |
| DOI: | 10.5213/inj.2448086.043 |
| Popis: | Purpose This study was performed to assess the risk factors for artificial urinary sphincter (AUS) explantation in a large multicenter cohort. Methods We retrospectively reviewed the medical records for all 1,233 implantations of the AMS-800 AUS device in male nonneurological patients from 2005 to 2020 across 13 French centers. Patients with neurological conditions were excluded from the study. To identify factors associated with explantation-free survival, survival analysis was performed. Explantation was defined as the complete removal of the device, whereas revision referred to the replacement of the device or its components. Results The study included 1,107 patients, of whom 281 underwent AUS explantation. The median survival without explantation was 83 months. The leading causes of explantation were infection and erosion. Univariate analysis revealed several significant risk factors for explantation: age above 75 years (34.6% in the explanted group vs. 25.8% in the nonexplanted group, P=0.007), history of radiotherapy (43.5% vs. 31.3%, P=0.001), and anticoagulant use (15% vs. 8.6%, P |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|